Julie W. Reeser

3.3k total citations · 2 hit papers
30 papers, 2.2k citations indexed

About

Julie W. Reeser is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Julie W. Reeser has authored 30 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Julie W. Reeser's work include Cancer Genomics and Diagnostics (11 papers), Fibroblast Growth Factor Research (10 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Julie W. Reeser is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Fibroblast Growth Factor Research (10 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Julie W. Reeser collaborates with scholars based in United States, Canada and France. Julie W. Reeser's co-authors include Sameek Roychowdhury, Jharna Miya, Melanie A. Krook, Michele R. Wing, Hui‐Zi Chen, Russell Bonneville, Lianbo Yu, Esko A. Kautto, Eric Samorodnitsky and Max Wilberding and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Julie W. Reeser

29 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Landscape of Microsatellite Instability Across 39 Cancer Types

2017 1.0k citations Russell Bonneville, Melanie A. Krook et al. JCO Precision Oncology profile →
Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance

2020 213 citations Melanie A. Krook, Julie W. Reeser et al. British Journal of Cancer profile →

Peers

Countries citing papers authored by Julie W. Reeser

Since Specialization

Citations

This map shows the geographic impact of Julie W. Reeser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie W. Reeser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie W. Reeser more than expected).

Fields of papers citing papers by Julie W. Reeser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie W. Reeser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie W. Reeser. The network helps show where Julie W. Reeser may publish in the future.

Co-authorship network of co-authors of Julie W. Reeser

This figure shows the co-authorship network connecting the top 25 collaborators of Julie W. Reeser. A scholar is included among the top collaborators of Julie W. Reeser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie W. Reeser. Julie W. Reeser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Growth factor receptor plasticity drives therapeutic persistence of metastatic breast cancer 2025 ·Cell Death and Disease ·(unknown), (unknown), (unknown), Julie W. Reeser, Emily C. Dykhuizen, Sameek Roychowdhury, Michael K. Wendt	1
2	Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib 2024 ·Haematologica ·(unknown), Benjamin H. Kaffenberger, Catherine Chung, Eric Samorodnitsky, Emily L. Hoskins, (unknown), Amy Smith, Sarah Wall, Jonathan E. Brammer, Julie W. Reeser, Michele R. Wing, Julia F. Hopkins, Lee A. Albacker, Lynne V. Abruzzo, (unknown), Aharon G. Freud, Sameek Roychowdhury, (unknown)	1
3	FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer 2024 ·npj Precision Oncology ·(unknown), Karthikeyan Murugesan, Julie W. Reeser, (unknown), Michele R. Wing, (unknown), Eric Samorodnitsky, Emily L. Hoskins, (unknown), Amy Smith, (unknown), Melissa A. Babcook, (unknown), Matthew R. Avenarius, (unknown), Aharon G. Freud, Sameek Roychowdhury	3
4	Stromal p53 Regulates Breast Cancer Development, the Immune Landscape, and Survival in an Oncogene-Specific Manner 2022 ·Molecular Cancer Research ·Jinghai Wu, Xin Liu, Julie W. Reeser, Anthony J. Trimboli, Thierry Pécot, Gina M. Sizemore, Shan K. Naidu, Soledad Fernández, Lianbo Yu, Michael Hallett, Morag Park, Gustavo Leone, Blake E. Hildreth, Michael C. Ostrowski	5
5	Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy 2021 ·JTO Clinical and Research Reports ·Hui‐Zi Chen, Russell Bonneville, (unknown), Julie W. Reeser, Michele R. Wing, Eric Samorodnitsky, Melanie A. Krook, Amy Smith, (unknown), Jharna Miya, Walter Wang, Lianbo Yu, Aharon G. Freud, (unknown), (unknown), Gregory A. Otterson, Peter G. Shields, David P. Carbone, Sameek Roychowdhury	13
6	Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma 2020 ·Molecular Cancer Therapeutics ·Melanie A. Krook, (unknown), Max Wilberding, (unknown), (unknown), Kelly M. Bailey, Hui‐Zi Chen, Julie W. Reeser, Michele R. Wing, Jharna Miya, Eric Samorodnitsky, Amy Smith, (unknown), (unknown), Kristen K. Ciombor, John L. Hays, Aharon G. Freud, Sameek Roychowdhury	106
7	Characterization of Clonal Evolution in Microsatellite Unstable Metastatic Cancers through Multiregional Tumor Sequencing 2020 ·Molecular Cancer Research ·Russell Bonneville, (unknown), Michele R. Wing, Melanie A. Krook, Julie W. Reeser, Hui‐Zi Chen, (unknown), Eric Samorodnitsky, Amy Smith, Lianbo Yu, (unknown), (unknown), Sameek Roychowdhury	7
8	Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance breakdown → 2020 ·British Journal of Cancer ·Melanie A. Krook, Julie W. Reeser, Gabrielle Ernst, (unknown), Max Wilberding, Gary Li, Hui‐Zi Chen, Sameek Roychowdhury	213
9	Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer 2019 ·Prostate Cancer and Prostatic Diseases ·Melanie A. Krook, (unknown), Hui‐Zi Chen, Julie W. Reeser, Michele R. Wing, (unknown), (unknown), (unknown), Russell Bonneville, Eric Samorodnitsky, Jharna Miya, Aharon G. Freud, J. Paul Monk, Steven K. Clinton, Sameek Roychowdhury	5
10	Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers 2019 ·Thyroid ·(unknown), Jerneja Tomšič, Ralf Bundschuh, Pamela Brock, Michelle D. Williams, Sameek Roychowdhury, Julie W. Reeser, Wendy L. Frankel, (unknown), Mark J. Routbort, Russell R. Broaddus, Paul E. Wakely, John E. Phay, Christopher J. Walker, Albert de la Chapelle	35
11	Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing 2019 ·Methods in molecular biology ·Russell Bonneville, Melanie A. Krook, Hui‐Zi Chen, Amy Smith, Eric Samorodnitsky, Michele R. Wing, Julie W. Reeser, Sameek Roychowdhury	53
12	Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy 2019 ·Molecular Case Studies ·Melanie A. Krook, Russell Bonneville, Hui‐Zi Chen, Julie W. Reeser, Michele R. Wing, (unknown), Amy Smith, (unknown), Eric Samorodnitsky, (unknown), Jharna Miya, (unknown), Lianbo Yu, Cynthia Timmers, (unknown), Aharon G. Freud, (unknown), Sameek Roychowdhury	63
13	Significant and Durable Clinical Response to Sorafenib and Radiation Therapy for a Patient With Stage IV Hepatocellular Carcinoma and LRRK2 Mutation 2019 ·JCO Precision Oncology ·Linlin Yang, (unknown), Sameek Roychowdhury, Anne M. Noonan, (unknown), Chia‐Chen Chuang, Julie W. Reeser, Evan Wuthrick, Carl Schmidt, Terence M. Williams	1
14	Abstract 335: Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma 2019 ·Melanie A. Krook, (unknown), Max Wilberding, (unknown), (unknown), Hui‐Zi Chen, Julie W. Reeser, Michele R. Wing, Jharna Miya, Eric Samorodnitsky, Amy M. Smith, (unknown), (unknown), (unknown), Kristen K. Ciombor, John L. Hays, Aharon G. Freud, Sameek Roychowdhury	1
15	Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity 2018 ·Molecular Case Studies ·Lorena P. Suarez‐Kelly, Keiko Akagi, Julie W. Reeser, Eric Samorodnitsky, (unknown), Amy Smith, Sameek Roychowdhury, David E. Symer, William E. Carson	6
16	Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398 2017 ·Molecular Cancer Therapeutics ·Jharna Datta, Senthilkumar Damodaran, (unknown), (unknown), Jharna Miya, Lianbo Yu, (unknown), Eric Samorodnitsky, Michele R. Wing, Darshna Bhatt, John L. Hays, Julie W. Reeser, Sameek Roychowdhury	72
17	Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations 2016 ·Journal of Visualized Experiments ·(unknown), Jharna Miya, Julie W. Reeser, Sameek Roychowdhury	13
18	Cancer Driver Log (CanDL) 2015 ·Journal of Molecular Diagnostics ·Senthilkumar Damodaran, Jharna Miya, Esko A. Kautto, (unknown), Eric Samorodnitsky, Jharna Datta, Julie W. Reeser, Sameek Roychowdhury	36
19	Evaluation of Hybridization Capture Versus Amplicon‐Based Methods for Whole‐Exome Sequencing 2015 ·Human Mutation ·Eric Samorodnitsky, (unknown), Raffi Hagopian, Jharna Miya, Michele R. Wing, (unknown), Senthilkumar Damodaran, Darshna Bhatt, Julie W. Reeser, Jharna Datta, Sukla Roychowdhury	175
20	Comparison of Custom Capture for Targeted Next-Generation DNA Sequencing 2014 ·Journal of Molecular Diagnostics ·Eric Samorodnitsky, Jharna Datta, (unknown), Raffi Hagopian, Jharna Miya, Michele R. Wing, Senthilkumar Damodaran, (unknown), Julie W. Reeser, Darshna Bhatt, Cynthia Timmers, Sukla Roychowdhury	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact